Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hepatitis C 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Burkitt Lymphoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 33fludarabine phosphate 31Peripheral Blood Stem Cell Transplantation 28Whole-Body Irradiation 27Rituximab 24Mycophenolic Acid 24Busulfan 22Cyclosporine 19Tacrolimus 17Etoposide 17Antilymphocyte Serum 17Filgrastim 14Methotrexate 12Melphalan 12Radiotherapy 10Granulocyte Colony-Stimulating Factor 8Cord Blood Stem Cell Transplantation 8thymoglobulin 6Sirolimus 6Carmustine 6Flow Cytometry 5Cytarabine 5ibritumomab tiuxetan 4Vincristine 4Prednisone 4Polymerase Chain Reaction 4Methylprednisolone 4Gene Expression Profiling 4Dexamethasone 4Cyclosporins 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, Large-Cell, Immunoblastic × Chromatography, High Pressure Liquid × Clear all
NCT00691652 2019-11-27

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma

OHSU Knight Cancer Institute

Phase 1/2 Terminated
2 enrolled 4 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡